Overall Technical outlook

Price Summary

GlaxoSmithKline Pharmaceuticals Limited's stock opened at 2772.6 on 2025-08-14, surged to a high of 2782.1, hit a low of 2687.2, and closed up -0.11% at 2769.6, with 116849 shares traded.
During the 52-week span, the stock hit a high of 3466.2 and a low of 1956.2.
4 analysts predict that the future price of GLAXO will be in the range of 2600.0 to 3500.0, with a mean expected price of about 3094.75.

Technicals

Support and Resistance: The price is currently at 2769.6, supported by 2759.9 and resisted by 2906.8. This indicates a range where 2759.9 may provide a base for the price, while 2906.8 serves as a cap on further upward movement for GLAXO.
GLAXO supportResistance 58763e
Support/Resistance for GLAXO


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLAXO aroon 58763e
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
GLAXO bbands 58763e
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, establishing a key support level that could sustain the market's upward trend. This support suggests that the bullish momentum is likely to persist, offering a foundation for further growth.
GLAXO psar 58763e
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for GlaxoSmithKline Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
GLAXO stoch 58763e
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO trippleSMA 58763e
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.